Colin Maher

Colin Maher has extensive experience in the legal field, with a focus on healthcare and pharmaceutical companies. Colin currently works as the General Counsel for Prospection, a healthcare data analytics company. Prior to this, they served as the General Counsel for Omniscient Neurotechnology (o8t), where they were responsible for establishing legal and regulatory structures for multiple territories. Colin also worked as the Regional Legal Director & Compliance Officer for Reckitt, leading legal and compliance matters related to RB Health ANZ commercial operations. Colin Maher has also held various roles at Novartis, including Head Legal, Oncology, Head of Legal, and Senior Legal Counsel. Colin started their legal career as a Senior Associate at CMS Cameron McKenna and later as a Senior Counsel at GlaxoSmithKline.

Colin Maher's education history includes several degrees and programs. Colin completed a Building Strategic Innovation Capability Program at the University of California, Berkeley, Haas School of Business in 2016. In the same year, they also obtained a Master of Business Administration (MBA) from Melbourne Business School. In 1999, they completed a Graduate Diploma in Legal Practice at The Australian National University, focusing on Law. Prior to that, in 1998, they obtained a Bachelor of Laws (LL.B.) from The University of Queensland. In the same year, they also completed a Bachelor of Arts (B.A.) in Political Economy from The University of Queensland.